• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Medicamen Biotech Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
531146
INE646B01010
206.2498198
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MEDICAMEQ
33.06
311.2
EPS(TTM)
Face Value()
Div & Yield %
6.94
10
0.44
 

mrf ltd
Shriram Finance consolidated net profit rises 40.92% in the March 2026 quarter
Apr 24,2026
Net profit of Shriram Finance rose 40.92% to Rs 3020.94 crore in the quarter ended March 2026 as against Rs 2143.77 crore during the previous quarter ended March 2025. Sales rose 9.44% to Rs 12306.75 crore in the quarter ended March 2026 as against Rs 11245.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 4.92% to Rs 10024.16 crore in the year ended March 2026 as against Rs 9553.82 crore during the previous year ended March 2025. Sales rose 14.96% to Rs 47508.48 crore in the year ended March 2026 as against Rs 41324.84 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales12306.7511245.00 9 47508.4841324.84 15
OPM %76.4672.57 -74.6472.65 -
PBDT4092.142943.04 39 13999.0911594.57 21
PBT3917.482771.98 41 13300.1910949.25 21
NP3020.942143.77 41 10024.169553.82 5